ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Calliditas Therapeutics Ab

Calliditas Therapeutics Ab (0A5R)

0.00
0.00
(0.00%)
Closed 12 January 3:30AM
Advanced chart

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

0A5R Latest News

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy PR Newswire STOCKHOLM, Aug. 18, 2023 STOCKHOLM, Aug. 18, 2023 /PRNewswire/ -- Calliditas Therapeutics...

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy

FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy PR Newswire STOCKHOLM, Aug. 18, 2023 STOCKHOLM, Aug. 18, 2023 /PRNewswire/ -- Calliditas Therapeutics...

Interim Report Q2, 2023: Calliditas Therapeutics

Interim Report Q2, 2023: Calliditas Therapeutics PR Newswire STOCKHOLM, Aug. 17, 2023 Filing for full approval of TARPEYO STOCKHOLM, Aug. 17, 2023 /PRNewswire/ -- FINANCIAL SUMMARY FOR THE...

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet PR Newswire STOCKHOLM, Aug. 15, 2023 STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas...

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet PR Newswire STOCKHOLM, Aug. 15, 2023 STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas...

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib PR Newswire STOCKHOLM, July 13, 2023 STOCKHOLM, July 13, 2023...

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib PR Newswire STOCKHOLM, July 13, 2023 STOCKHOLM, July 13, 2023...

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® PR Newswire STOCKHOLM, June 21, 2023 STOCKHOLM, June 21, 2023...

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®

Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® PR Newswire STOCKHOLM, June 21, 2023 STOCKHOLM, June 21, 2023...

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ) PR Newswire STOCKHOLM, May 30, 2023 STOCKHOLM, May 30, 2023 /PRNewswire/ -- The following resolutions were passed at...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0A5R - Frequently Asked Questions (FAQ)

What is the current Calliditas Therapeutics Ab share price?
The current share price of Calliditas Therapeutics Ab is SEK 0.00
What is the 1 year trading range for Calliditas Therapeutics Ab share price?
Calliditas Therapeutics Ab has traded in the range of SEK 0.00 to SEK 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
4.60p
(43.75%)
10.46M
APHAlliance Pharma Plc
61.10p
(37.77%)
39.55M
NFXNuformix Plc
0.065p
(36.84%)
93.97M
PRMProteome Sciences Plc
4.50p
(31.58%)
1.06M
RCGHRc365 Holding Plc
2.10p
(31.25%)
2.88M
NTQEnteq Technologies Plc
0.775p
(-75.00%)
7.81M
JWNGJaywing Plc
0.625p
(-58.33%)
1.91M
MFAIMindflair Plc
0.825p
(-28.88%)
119.03M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
GEXGeorgina Energy Plc
6.625p
(-22.06%)
5.72M
TRPTower Resources Plc
0.0395p
(6.76%)
9.11B
NTVONativo Resources Plc
0.002p
(-9.09%)
1.27B
DGIDg Innovate Plc
0.0185p
(0.00%)
544.86M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
MSMNMosman Oil And Gas Limited
0.033p
(-2.94%)
445.45M

Discussion

View Full Feed
Tiger Money Tiger Money 53 seconds ago
I have $20k of my xrp holdings locked down and taken off the chain for five years.  I will be selling half of that for potentially $20 million 
XRPUSD
hap0206 hap0206 2 minutes ago
Oh my goodness -- a fact sheet from the environmental fanatics -- let's look at those facts
====
Direct subsidies

Intangible Drilling Costs Deduction (26 U.S. Code § 263. Active). This provision allows companies to deduct a majority of the costs incurred from drilling ne
tjvs tjvs 3 minutes ago
You should know the answer to that if you were an investor in tsoi and got the divi in cnsi
TSOI
jour_trader jour_trader 4 minutes ago
I didn't you did. Zoetis was in one of the companies you provided dude. Stop using ChatGPT as a resource. It isn't helping you if you don't understand where it fails. 
ELTP
JPetroInc JPetroInc 5 minutes ago
AI and Quantum Computing...

2 exceptionally hot industries mentioned as potential merger candidates in the Jan 2nd press release

with fully reporting Pink current status in exploration stages of strategic alternatives to maximize SH value

“There have bee
GCAN
toohot toohot 5 minutes ago
BIEL will be coming alive in ‘25.
‘Nuff said!




BUY $BIEL$
BIEL
benyam benyam 6 minutes ago
next week highlight moni ,umav
BBANBOB BBANBOB 6 minutes ago
SO DO NOT RESPOND and there will be tons less BS CLUTTER

IT is up to every poster on this board ifin he gets air time or not DON'T GIVE IT TO HIM
COOP
BBANBOB BBANBOB 8 minutes ago
YOU BLEW IT PARD SORRY TO SAY. Not criticizing you but what did ya even buy an BULL ELK tag for ifin ya didn't even KNOW WHAT HELL THEY LOOK LIKE
COOP
WhenLambo WhenLambo 9 minutes ago
Divi Wallet is huge 🪙
TPTW
Jetmek_03052 Jetmek_03052 9 minutes ago
Pretty tight little channel between $130 and $150.

With the fourth Q coming out in a month or so? I'll bet the breakout is to the upside.
NVDA
al44 al44 9 minutes ago
Last I heard they go a grand total of 9 installed. I would not be surprised if the rest of the money went to coddle illegal aliens.

...................al
luvwetscent luvwetscent 10 minutes ago
500 mil in revenues?..as Jour said, market is forward looking and it obviously doesn't agree with that figure..but what do I know?
ELTP
zab zab 10 minutes ago
My wife just filled her Malibu, less than $30.00, and I did my Acura,  premium gas less than $36.00. So how much lower. Let us not forget those eggs, bought 18 for less than $3.00.it means so much. No excuses,  remember it's trump,  30 days is plenty of time to display some changes. 
Seminole Red Seminole Red 11 minutes ago
PFIZER JUST RELEASED ITS LIST OF SIDE EFFECTS OF ITS "COVID VACCINE"💉
The list of some side effects of the Pfizer-Biontech Covid-19 Vaccine. 💉
Blood thrombosis.
Acute kidney injury,
Acute flaccid myelitis,
Positive antisperm antibodies,
Brai
lodas lodas 11 minutes ago
@ joniconfer... thanks for the concern... the fire is about 3 miles from me, as I live in the S.F.Valley... the fire last night got to the intersection of the 405 freeway and ventura blvd, and was threatening Encino... so yea, It is close... the only thing that saved the fire from coming into the va
COOP
misterfishman misterfishman 11 minutes ago
They said no RS planned.
RDAR
I-Glow I-Glow 12 minutes ago
Odd that Park didn't inform shareholders about increasing the A/S.

IG
SPZI
sortagreen sortagreen 13 minutes ago
"And i always thought one day was 24 hours."

Apparently he didn't mean 24 hours in a row...
blackhawks blackhawks 13 minutes ago
Industrialization, the use of fossil fuels, is roughly 150 years old, and you've been around almost since it began to expanded worldwide. Wrap your little mind on what's happening NOW.

There is absolutely no science to support your fatuous claim that climate change is not man made, n
HGilS HGilS 14 minutes ago
To estimate the price per share of Elite Pharmaceuticals (ELTP) based on an annual revenue of $500 million, we can use the Price-to-Sales (P/S) ratio from their financial reports. The P/S ratio is calculated as:

\text{P/S Ratio} = \frac{\text{Market Cap}}{\text{Annual Revenue}}
ELTP

Your Recent History

Delayed Upgrade Clock